美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BlossomHill Therapeutics

17.80

+1.7711.04%

成交量：11.21萬

成交額：190.51萬

市值：5.45億

市盈率：-7.28

高：17.96

開：16.10

低：16.10

收：16.03

52周最高：17.96

52周最低：15.25

股本：3,064.37萬

流通股本：937.50萬

量比：0.78

換手率：1.20%

股息：- -

股息率：- -

每股收益(TTM):-2.4440

每股收益(LYR):-24.8342

淨資產收益率：--

總資產收益率：--

市淨率：-3.59

市盈率(LYR):-0.72

資料載入中...

總覽公司新聞資訊公告

Blossomhill Therapeutics宣佈其宏環Omni-Egfr™抑制劑Bh-30643獲FDA快速通道資格，用於治療晚期EGFR C797S突變非小細胞肺癌

美股異動 | BlossomHill Therapeutics(BLSM.US)登陸美股市場開盤後股價小幅走低

BlossomHill Therapeutics 1.5億美元增額IPO後料平淡上市

小分子抗癌療法開發商BlossomHill(BLSM.US)IPO定價15-17美元/股擬籌資1.25億美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/BLSM/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BLSM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLSM\",,,,,undefined,":{"symbol":"BLSM","market":"US","secType":"STK","nameCN":"BlossomHill Therapeutics","latestPrice":17.8,"timestamp":1787681556939,"preClose":16.03,"halted":0,"volume":112116,"delay":0,"changeRate":0.11041796631316278,"floatShares":9375000,"shares":30643700,"eps":-2.444,"marketStatus":"交易中","change":1.77,"latestTime":"08-25 14:14:58 EDT","open":16.1,"high":17.96,"low":16.1,"amount":1905071.484288,"amplitude":0.116032,"askPrice":17.95,"askSize":200,"bidPrice":17.61,"bidSize":14,"shortable":3,"etf":0,"ttmEps":-2.444,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"listingDate":1786075200000,"exchange":"NASDAQ","adjPreClose":16.03,"postHourTrading":{"tag":"盘后","latestPrice":15.95,"preClose":16.03,"latestTime":"19:30 EDT","volume":307,"amount":4897.13,"timestamp":1787614207302,"change":-0.08,"changeRate":-0.004991,"amplitude":0},"volumeRatio":0.782348},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLSM\",,,,,undefined,":{"symbol":"BLSM","floatShares":9375000,"roa":"--","roe":"--","lyrEps":-24.834182,"volumeRatio":0.782348,"shares":30643700,"dividePrice":0,"high":17.96,"amplitude":0.116032,"preClose":16.03,"low":16.1,"week52Low":15.25,"pbRate":"-3.59","week52High":17.96,"institutionHeld":0,"latestPrice":17.8,"committee":-0.869159,"eps":-2.444,"divideRate":0,"volume":112116,"delay":0,"ttmEps":-2.444,"open":16.1,"prevYearClose":16,"prevWeekClose":16.38,"prevMonthClose":16,"prevQuarterClose":16,"fiveDayClose":16.1,"twentyDayClose":16,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLSM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLSM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BLSM\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BLSM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BLSM","date":"2026-08-21","current":-6.55892,"percent":0.909091,"low":-7.12152,"twenty":-7.038752,"median":-6.955553,"eighty":-6.893907,"high":-2.788792,"avg":-6.617124,"sd":1.157195,"marketCap":484169828},"quantilePoints":[{"date":"2026-08-07","current":-6.897356,"twenty":-6.075643,"median":-4.843074,"eighty":-3.610505,"marketCap":490298560},{"date":"2026-08-14","current":-7.048236,"twenty":-7.038752,"median":-6.897356,"eighty":-6.893907,"marketCap":501023841},{"date":"2026-08-21","current":-6.811139,"twenty":-7.038752,"median":-6.955553,"eighty":-6.893907,"marketCap":484169828}],"updateTime":1787645480563},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLSM\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1162137187","title":"Blossomhill Therapeutics宣佈其宏環Omni-Egfr™抑制劑Bh-30643獲FDA快速通道資格，用於治療晚期EGFR C797S突變非小細胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1162137187","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162137187?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 19:01","pubTimestamp":1787050871,"startTime":"0","endTime":"0","summary":"Blossomhill Therapeutics今日宣布，美国食品药品监督管理局已授予其候选药物Bh-30643快速通道资格。该药物是一种宏环Omni-Egfr抑制剂，专为治疗携带EGFR C797S突变的晚期非小细胞肺癌患者而设计。这一资格认定意味着Bh-30643有望加速开发和审评进程，以应对当前未被满足的医疗需求。EGFR C797S突变常被视为对现有靶向治疗产生耐药性的关键机制之一，临床挑战严峻。Blossomhill Therapeutics表示，获得快速通道资格是其推进创新疗法过程中的重要里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657640472","title":"美股異動 | BlossomHill Therapeutics(BLSM.US)登陸美股市場 開盤後股價小幅走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2657640472","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657640472?lang=zh_tw&edition=fundamental","pubTime":"2026-08-08 00:00","pubTimestamp":1786118400,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，BlossomHill Therapeutics登陆美股市场，截至发稿，该股跌超1%，报15.8美元。BlossomHill Therapeutics总部位于加州圣地亚哥，成立于2020年。该公司专注于通过识别现有治疗方法中的结构性弱点，并设计新的化合物来克服这些弱点，从而开发小分子癌症药物。公司计划于2026年第四季度与美国食品药品监督管理局举行一期临床结束会议，讨论推荐的二期临床给药方案，以及针对部分患者潜在的加速批准路径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477624.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BLSM","LENZ","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657264457","title":"BlossomHill Therapeutics 1.5億美元增額IPO後料平淡上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2657264457","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657264457?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 22:24","pubTimestamp":1786112666,"startTime":"0","endTime":"0","summary":"BUZZ-BlossomHill Therapeutics 1.5亿美元增额IPO后料平淡上市8月7日-** 药物开发商BlossomHill Therapeutics在1.5亿美元增额IPO后，纳斯达克首日上市预计将持平开盘** 该股最新显示开盘价为每股16.05美元，而发行价为16美元** 总部位于加利福尼亚州圣地亚哥的BLSM公司通过规模扩大的首次公开募股，以每股16美元的价格售出约940万股 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL4T44417W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4207","BLSM","MNSH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656536749","title":"小分子抗癌療法開發商BlossomHill(BLSM.US)IPO定價15-17美元/股 擬籌資1.25億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2656536749","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656536749?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 16:47","pubTimestamp":1785833278,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS","UUP","BLSM","UDN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}]}}